US-based Eli Lilly wants build on its strong momentum and outperform Novo Nordisk in the global obesity market, says the company’s executive vice president. Analyst still sees the battle as wide open.
发布者:BY IDA JORGENSEN,转转请注明出处:https://robotalks.cn/eli-lilly-overtook-novo-nordisk-in-the-us-next-step-is-global-leadership/